Fontolizumab

Drug Profile

Fontolizumab

Alternative Names: Anti-IFN-gamma monoclonal antibody - Protein Design Labs; Anti-interferon-gamma monoclonal antibody - Protein Design Labs; HuZAF; SMART anti-gamma interferon antibody

Latest Information Update: 19 Jun 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator PDL BioPharma
  • Class Anti-inflammatories; Monoclonal antibodies
  • Mechanism of Action Interferon gamma inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Autoimmune disorders; Crohn's disease; Psoriasis; Rheumatoid arthritis

Most Recent Events

  • 09 Jan 2006 Protein Design Labs is now called PDL BioPharma
  • 31 Dec 2005 Phase-II clinical trials in Rheumatoid arthritis in USA (unspecified route)
  • 22 Dec 2005 Phase-II clinical trials in Crohn's disease in Europe (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top